Stem Cell Center
281 – 290 of 807
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Coexpression of hyperactivated AKT1 with additional genes activated in leukemia drives hematopoietic progenitor cells to cell cycle block and apoptosis.
(
- Contribution to journal › Article
-
Mark
Anti-endotoxic and antibacterial effects of a dermal substitute coated with host defense peptides.
(
- Contribution to journal › Article
-
Mark
Cellular origin of prognostic chromosomal aberrations in AML patients.
(
- Contribution to journal › Letter
-
Mark
Does Low-Molecular-Weight Heparin Influence the Antimyeloma Effects of Thalidomide? A Retrospective Analysis of Data from the GIMEMA, Nordic and Turkish Myeloma Study Groups
(
- Contribution to journal › Article
-
Mark
Islet-specific monoamine oxidase A and B expression depends on MafA transcriptional activity and is compromised in type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Recurrent mutations refine prognosis in chronic lymphocytic leukemia.
(
- Contribution to journal › Article
-
Mark
ERG promotes the maintenance of hematopoietic stem cells by restricting their differentiation.
(
- Contribution to journal › Article
-
Mark
Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: A report from the Swedish Acute Leukemia Registry
(
- Contribution to journal › Article
-
Mark
Regulation of advanced therapy medicinal products will affect the practice of haematopoietic SCT in the near future: a perspective from the EBMT cell-processing committee.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk.
(
- Contribution to journal › Letter